The contribution of endogenous sources of DNA damage to the multiple mutations in cancer

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 477, Issue 1-2, 2001, Pages 7-21

  Jackson, Aimee L ^a   Loeb, Lawrence A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Genetic instability; Mutation; Oxygen; Tumor

Indexed keywords

MICROSATELLITE DNA; REACTIVE OXYGEN METABOLITE;

CANCER; CARCINOGENESIS; CHROMOSOME ABERRATION; CHRONIC HEPATITIS; DEAMINATION; DNA DAMAGE; DNA REPAIR; GASTRITIS; GENE MUTATION; HUMAN; MICROSATELLITE INSTABILITY; MUTATION RATE; OXIDATION; PANCREATITIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TUMOR CELL; ULCERATIVE COLITIS;

ANIMALS; ANTIOXIDANTS; CELL TRANSFORMATION, NEOPLASTIC; DNA DAMAGE; FORECASTING; HUMANS; INFLAMMATION; MUTATION; NEOPLASMS; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES;

EID: 0035796023     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(01)00091-4     Document Type: Review

References (128)

1. Loeb L.A., Springgate C.F., Battula N. Errors in DNA replication as a basis of malignant change. Cancer Res. 34:1974;2311-2321.
2. Loeb L.A. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res. 51:1991;3075-3079.
3. Jackson A.L., Loeb L.A. The mutation rate and cancer. Genetics. 148:1998;1483-1490.
4. Duesberg P., Rausch C., Rasnick D., Hehlmann R. Genetic instability of cancer cells is proportional to their degree of aneuploidy. Proc. Natl. Acad. Sci. U.S.A. 95:1998;13692-13697.
5. Rasnick D., Duesberg P.H. How aneuploidy affects metabolic control and causes cancer. Biochem. J. 340:1999;621-630.
6. Hartwell L.H., Kastan M.B. Cell cycle control and cancer. Science. 266:1994;1821-1827.
7. Rowley J.D. Nonrandom chromosomal abnormalities in hematologic disorders of man. Proc. Natl. Acad. Sci. U.S.A. 72:1975;152-156.
8. Balaban G.B., Herlyn M., Clark W.H. Jr., Nowell P.C. Karyotypic evolution in human malignant melanoma. Cancer Genet. Cytogenet. 19:1986;113-122.
9. Naylor S.L., Johnson B.E., Minna J.D., Sakaguchi A.Y. Loss of heterozygosity of chromsome 3p markers in small-cell lung cancer. Nature. 329:1987;451-454.
10. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 61:1990;759-767.
11. Paulovich A.G., Toczyski D.P., Hartwell L.H. When checkpoints fail. Cell. 88:1997;315-321.
12. Tlsty T.D., Margolin B.H., Lum K. Differences in the rates of gene amplification in nontumorigenic and tumorigenic cell lines as measured by Luria-Delbruck fluctuation analysis. Proc. Natl. Acad. Sci. U.S.A. 86:1989;9441-9445.
13. Kallioniemi A., Kallioniemi O.-P., Piper J., Tanner M., Stokke T., Chen L., Smith H.S., Pinkel D., Gray J.W., Waldman F.M. Detecton and mapping of amplified DNA sequences in breast cancer by comparative gnomic hybridization. Proc. Natl. Acad. Sci. U.S.A. 91:1994;2156-2160.
14. Iwabuchi H., Sakamoto M., Sakunaga H., Ma Y.Y. Genetic analysis of benign, low-grade, and high-grade ovarian tumors. Cancer Res. 55:1995;6172-6180.
15. Riopel M.A., Spellerberg A., Griffin C.A., Perlman E.J. Genetic analysis of ovarian germ cell tumors by comparative genomic hybridization. Cancer Res. 58:1998;3105-3110.
16. El-Rifai W., Sarlomo-Rikala M., Knuutila S., Miettinen M. DNA copy number changes in development and progression in leiomyosarcomas of soft tissues. Am. J. Pathol. 153:1998;985-990.
17. Knuutila S., Bjorkqvist A.-M., Autio K., Tarkkanen M., Wolf M., Monni O., Szymanska J., Larramendy M.L., Tapper J., Pere H., El-Rifai W., Hemmer S., Wasenius V.-M., Vidgren V., Zhu Y. DNA copy number amplifications in human neoplasms. Am. J. Pathol. 152:1998;1107-1123.
18. Klein C.A., Schmidt-Kittler O., Schardt J.A., Pantel K., Speicher M.R., Riethmuller G. Comparative gnomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. Proc. Natl. Acad. Sci. U.S.A. 96:1999;4494-4499.
19. Bentz M., Plesch A., Stilgenbauer S., Dohner H., Lichter P. Minimal sizes of deletions detected by comparative genomic hybridization, genes, chromosomes. Cancer. 21:1998;172-175.
20. Karangueven F., Noguchi T., Coulier F., Allione F., Wargniez V., Simony-Lafontaine J., Longy M., Jacquemier J., Sobol H., Eisinger F., Birnbaum D. Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas. Cancer Res. 57:1997;5469-5474.
21. Jackson A.L., Loeb L.A. On the origin of multiple mutations in human cancers. Sem. Cancer Biol. 8:1998;421-429.
22. Ionov Y., Peinado M.A., Malkhosyan S., Shibata S., Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature. 363:1993;558-561.
23. Strand M., Prolla T.A., Liskay R.M., Petes T.D. Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair. Nature. 365:1993;274-276.
24. Fishel R., Lescoe M.K., Rao M.R.S., Copeland N.G., Jenkins N.A., Garber J., Kane M., Kolodner R. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell. 75:1993;1027-1038.
25. Leach F.S., Nicolaides N.C., Papadopoulos N., Liu B., Jen J., Parsons R., Peltomaki R., Sistonen P., Aaltonen L.A., Nystrom-Lahti M., Guan X.-Y., Zhang J., Meltzer P.S., Yu J.-W., Kao F.-T., Chen D.J., Cerosaletti K.M., Fournier R.E.K., Todd S., Lewis T. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell. 75:1993;1215-1225.
26. Papadopoulos N., Nicolaides N.C., Wei Y.-F., Ruben S.M., Carter K.C., Rosen C.A., Haseltine W.A., Fleischmann R.D., Fraser C.M., Adams M.D., Venter J.C., Hamilton S.R., Petersen G.M., Watson P., Lynch H.T., Peltomaki P., Mecklin J.-P., de la Chapelle A., Kinzler K.W., Vogelstein B. Mutation of a mutL homolog in hereditary colon cancer. Science. 263:1994;1625-1629.
27. Yamamoto H., Sawai H., Weber T.K., Rodriguez-Bigas M.A., Perucho M. Somatic frameshift mutations in DNA mismatch repair and proapoptosis genes in hereditary nonpolyposis colorectal cancer. Cancer Res. 58:1998;997-1003.
28. Huang J., Papadopoulos N., McKinley A.J., Farrington S.M., Curtis L.J., Wyllie A.H., Zheng S., Willson J.K.V., Markowitz S.S., Morin P., Kinzler K.W., Vogelstein B., Dunlop M.G. APC mutations in colorectal tumors with mismatch repair deficiency. Proc. Natl. Acad. Sci. U.S.A. 93:1996;9049-9054.
29. Markowitz S., Wang J., Myeroff L., Parsons R., Sun L.Z., Lutterbaugh J., Fan R.S., Zborowska E., Kinzler K.W., Vogelstein B., Brattain M., Willson J.K.V. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science. 268:1995;1336-1338.
30. Togo G., Toda N., Kanai F., Kato N., Shiratori Y., Kishi K., Imazeki F., Makuuchi M., Omata M. A transforming growth factor β type II receptor gene mutation common in sporadic cecum cancer with microsatellite instability. Cancer Res. 56:1996;5620-5623.
31. Parsons R., Myeroff L.L., Liu B., Willson J.K.V., Markowitz S.D., Kinzler K.W., Vogelstein B. Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer. Cancer Res. 55:1995;5548-5550.
32. R.F. Souza, R. Appel, J. Yin, S. Wang, K.N. Smolinski, J.M. Abraham, T.T. Zou, Y.Q. Shi, J. Lei, J. Cottrell, K. Cymes, K. Biden, L. Simms, B. Leggett, P.M. Lynch, M. Frazier, S.M. Powell, N. Harpaz, H. Sugimura, J. Young, Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours [letter], Nat. Genet. 14 (1996) 255-257 [published erratum appears in Nat. Genet. 14 (4) (1996) 488].
33. R.F. Souza, R. Appel, J. Yin, S. Wang, K.N. Smolinski, J.M. Abraham, T.T. Zou, Y.Q. Shi, J. Lei, J. Cottrell, K. Cymes, K. Biden, L. Simms, B. Leggett, P.M. Lynch, M. Frazier, S.M. Powell, N. Harpaz, H. Sugimura, J. Young, Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours [letter], Nat. Genet. 14 (1996) 255-257 [published erratum appears in Nat. Genet. 14 (4) (1996) 488].
34. Rampino N., Yamamoto H., Ionov Y., Li Y., Sawai H., Reed J.C., Perucho M. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science. 275:1997;967-969.
35. Kouri M., Laasonen A., Mecklin J.P., Jarvinen H., Franssila K., Pyrhonen S. Diploid predominance in hereditary nonpolyposis colorectal carcinoma evaluated by flow cytometry. Cancer. 65:1990;1825-1829.
36. Frei J.V. Hereditary nonpolyposis colorectal cancer (Lynch syndrome II). Diploid malignancies with prolonged survival. Cancer. 69:1992;1108-1111.
37. Shibata D., Peinado M.A., Ionov Y., Malkhosyan S., Perucho M. Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation. Nat. Genet. 6:1994;273-281.
38. C.S. Muir, J. Nectoux, International patterns of cancer, in: D. Shottenfeld, J.F. Fraumeni (Eds.), Cancer Epidemiology and Prevention, W.B. Saunders Co., Philadelphia, 1982, pp. 119-135.
39. R.W. Miller, Geographical and ethnic differences in the occurrence of childhood cancer, in: D.M. Prkin, et al. (Eds.), International Incidence of Childhood Cancer, International Agency for Research on Cancer, Lyon, France, 1988, pp. 3-7.
40. Lindahl T., Nyberg B. Rate of depurination of native deoxyribonucleic acid. Biochemistry. 11:1972;3610-3618.
41. Schaaper R.M., Koplitz R.M., Tkeshelashvili L.K., Loeb L.A. Metal-induced lethality and mutagenesis: possible role of apurinic intermediates. Mutat. Res. 177:1987;179-188.
42. Nakamura J., Swenberg J.A. Endogenous apurinic/apyrimidinic sites in genomic DNA of mammalian tissues. Cancer Res. 59:1999;2522-2526.
43. Loeb L.A., Preston B.D. Mutagenesis by apurinic/apyrimidinic sites. Ann. Rev. Genet. 20:1986;210-230.
44. Hussain S.P., Harris C.C. Molecular epidemiology of human cancer: contribution of mutation spectra studies of tumor suppressor genes. Cancer Res. 58:1998;4023-4037.
45. Lindahl T., Nyberg B. Heat-induced deamination of cytosine residues in deoxyribonucleic acid. Biochemistry. 13:1974;3405-3410.
46. Duncan B.K., Miller J.H. Mutagenic deamination of cytosine residues in DNA. Nature. 287:1980;560-561.
47. Impellizzeri K.J., Anderson B., Burgers P.M. The spectrum of spontaneous mutations in a saccharomyces cerevisiae uracil-DNA-glycosylase mutant limits the function of this enzyme to cytosine deamination repair. J. Bacteriol. 173:1991;6807-6810.
48. Rideout W.M.d., Coetzee G.A., Olumi A.F., Jones P.A. 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science. 249:1990;1288-1290.
49. Washington S.L., Yoon M.S., Chagovetz A.M., Li S.X., Clairmont C.A., Preston B.D., Eckert K.A., Sweasy J.B. A genetic system to identify DNA polymerase β mutator mutants. Proc. Natl. Acad. Sci. U.S.A. 94:1997;1321-1326.
50. Umar A., Kunkel T.A. DNA-replication fidelity mismatch repair and genomic instability in cancer cells. Eur. J. Biochem. 238:1996;297-307.
51. Syvaoja J., Suomensaari S., Nishida C., Goldsmith J.S., Chui G.S.J., Jain S., Linn S. DNA polymerases α, δ and ε: three distinct enzymes from HeLa cells. Proc. Natl. Acad. Sci. U.S.A. 87:1990;6664-6668.
52. Hindges R., Hubscher U. Production of active mouse DNA polymerase delta in bacteria. Gene. 158:1995;241-246.
53. Schaaper R.M. Base selection, proofreading, and mismatch repair during DNA replication in Escherichia coli. J. Biol. Chem. 268:1993;23762-23765.
54. Modrich P., Lahue R. Mismatch repair in replication fidelity, genetic recombination and cancer biology. Annu. Rev. Biochem. 65:1996;101-133.
55. Wang H., Lawrence C.W., Li G.-M., Hays J.B. Specific binding of human MSH2-MSH6 mismatch-repair protein heterodimers to DNA incorporating thymine- or uracil-containing UV light photoproducts opposite mismatched bases. J. Biol. Chem. 274:1999;16894-16900.
56. M. Meuth, Patterns of mutation in cancer cells, in: T. Lindahl (Ed.), Cancer Surveys, Cold Spring Harbor Laboratory Press, Plainview, New York, 1996, pp. 33-46.
57. Musk P., Clark J.M., Thompson D., Dunn I.S., Christopherson R.I., Szabados E., Rose S.E., Parsons P.G. Purine deoxynucleoside metabolism in human melanoma cells with a high spontaneous mutation rate. Mutat. Res. 350:1996;229-238.
58. Fry M., Loeb L.A. The fragile X syndrome d[CGC]n nucleotide repeats form a stable tetrahelical structure. Proc. Natl. Acad. Sci. 91:1994;4950-4954.
59. Mozzherin D.J., McConnell M., Jasko M.V., Krayevsky A.A., Tan C.-K., Downey K.M., Fisher P.A. Proliferating cell nuclear antigen promotes misincorporation catalyzed by calf thymus DNA polymerase δ J. Biol. Chem. 271:1996;31711-31717.
60. Sweasy J.B., Loeb L.A. Mammalian DNA polymerase β can substitute for DNA polymerase I during DNA replication in Escherichia coli. J. Biol. Chem. 267:1992;1407-1410.
61. Sobol R.W., Horton J.K., Kuhn R., Gu H., Singhal R.K., Prasad R., Rajewsky K., Wilson S.H. Requirement of mammalian DNA polymerase-β in base-excision repair. Nature. 379:1996;183-186.
62. Srivastava D.K., Husain I., Arteaga C.L., Wilson S.H. DNA polymerase beta expression differences in selected human tumors and cell lines. Carcinogenesis. 20:1999;1049-1054.
63. Clairmont C.A., Sweasy J.B. Dominant negative rat DNA polymerase β mutants interfere with base excision repair in Saccharomyces cerevisiae. J. Bacteriol. 178:1996;656-661.
64. Canitrot Y., Cazaux C., Frechet M., Bouayadi K., Lesca C., Salles B., Hoffmann J.-S. Overexpression of DNA polymerase β in cell results in a mutator phenotype and a decreased sensitivity to anticancr drugs. Proc. Natl. Acad. Sci. U.S.A. 95:1998;12586-12590.
65. Canitrot Y., Frechet M., Servant L., Cazaux C., Hoffmann J.-S. Overexpression of DNA polymerase β: a genomic instability enhancer process. FASEB J. 13:1999;1107-1111.
66. Witkin E.M. Ultraviolet mutagenesis and inducible DNA repair in Escherichia coli. Bacteriol. Rev. 40:1976;869-907.
67. Murli S., Walker G.C. SOS mutagenesis. Curr. Opin. Genet. Dev. 3:1993;719-725.
68. 2C is an error-prone DNA polymerase, Escherichia coli Pol V. Proc. Natl. Acad. Sci. U.S.A. 96:1999;8919-8924.
69. Nelson J.R., Lawrence C.W., Hinkle D.C. Thymine-thymine dimer bypass by yeast DNA polymerase ζ Science. 272:1996;1646-1649.
70. Johnson R.E., Kondratick C.M., Prakash S., Prakash L. hRAD30 mutations in the variant form of xeroderma pigmentosum. Science. 285:1999;263-265.
71. Johnson R.E., Prakash S., Prakash L. Efficient bypass of a thymine-thymine dimer by yeast DNA polymerase, Pol η Science. 283:1999;1001-1004.
72. Tang M., Pham P., Shen X., Taylor J.S., O'Donnell M., Woodgate R., Goodman M.F. Roles of E. coli DNA polymerases IV and V in lesion-targeted and untargeted SOS mutagenesis. Nature. 404:2000;1014-1018.
73. Masutani C., Araki M., Yamada A., Kusumoto R., Nogimori T., Maekawa T., Iwai S., Hanaoka F. Xeroderma pigmentosum variant (XP-V) correcting protein from HeLa cells has a thymine dimer bypass DNA polymerase activity. EMBO J. 18:1999;3491-3501.
74. Masutani C., Kusumoto R., Yamada A., Dohmae N., Yokoi M., Yuasa M., Araki M., Iwai S., Takio K., Hanaoka F. The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase η (see comments). Nature. 399:1999;700-704.
75. Johnson R.E., Prakash S., Prakash L. The human DINB1 gene encodes the DNA polymerase Pol theta. Proc. Natl. Acad. Sci. U.S.A. 97:2000;3838-3843.
76. Friedberg E.C., Gerlach V.L. Novel DNA polymerases offer clues to the molecular basis of mutagenesis. Cell. 98:1999;413-416.
77. S.J. Klebanoff, Phagocytic cells: Products of oxygen metabolism, in: J.I. Gallin, I.M. Goldstein, R. Snyderman (Eds.), Inflammation: Basic Principles Clinical Correlates, Raven Press, New York, 1988, pp. 391-444.
78. T.G. Newcomb, L.A. Loeb, Oxidative DNA damage and mutagenesis, in: J.A. Nickoloff, M.F. Hoekstra (Eds.), DNA Damage and Repair in Prokaryotes and Lower Eukaryotes, Humana Press, Totowa, NJ, 1998, pp. 1-18.
79. R.A. Floyd, Measurement of oxidative stress in vivo, in: K.J.A. Daview, F. Ursini (Eds.), The Oxygen Paradox, Cleup University Press, Cleup, 1995, pp. 89-103.
80. Beckman K.B., Ames B.N. Oxidative decay of DNA. J. Biol. Chem. 272:1997;19633-19636.
81. Cerutti P.A. Prooxidant states and tumor promotion. Science. 227:1985;375-381.
82. Slaga T.J., Klein-Szanto A.J.P., Triplett L.L., Yotti L.P., Trosko J.E. Skin-tumor-promoting activity of benzoyl peroxide, a widely used free radical-generating compound. Science. 213:1981;1023-1025.
83. B.G. Taffe, T.W. Kensler, N. Takahashi, R.P. Mason, Activation of organic hydroperoxide tumor promoters to free radicals in target cells, in: P.A. Cerutti, O.F. Nygaard, M.G. Simic (Eds.), Anticarcinogenesis and Radiation Protection, Plenum Press, New York, 1987, pp. 191-197.
84. Weitzman S.A., Weitberg A.B., Clark E.P., Stossel T.P. Phagocytes as carcinogens: malignant transformation produced by human neutrophils. Science. 227:1985;1231-1233.
85. Ames B.N. Dietary carcinogens and anticarcinogens. Science. 221:1983;1256-1263.
86. Perchellet J.-P., Perchellet E.M. Antioxidants and multistage carcinogenesis in mouse skin. Free Rad. Biol. Med. 7:1989;377-408.
87. 2-generating peroxisomal urate oxidase. Cancer Res. 56:1996;4846-4852.
88. 2-generating peroxisomal fatty acyl-CoA oxidase. Int. J. Cancer. 17:1997;716-721.
89. Suh Y.-A., Arnold R.S., Lassegue B., Shi J., Xu S., Sorescu D., Chung A.B., Griendling K.K., Lambeth J.D. Cell transformation by the superoxide-generating oxidase Mox1. Nature. 401:1999;79-82.
90. Cadet J., Berger M. Radiation-induced decomposition of the purine bases within DNA and related model compunds. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 47:1985;127-143.
91. Loeb L.A. Apurinic sites as mutagenic intermediates. Cell. 40:1985;483-484.
92. Purmal A.A., Kow Y.W., Wallace S.S. Major oxidative products of cytosine, 5-hydroxycytosine and 5-hydroxyuracil, exhibit sequence context-dependent mispairing in vitro. Nucl. Acids Res. 22:1994;72-78.
93. Polverelli M., Teoule R. Gamma irradiation of cytosine in an aerated aqueous solution. I. Identification of radiolysis products of cytosine resulting from the deamination pathway. Z. Naturforsch C. 29:1974;12-15.
94. Feig D.I., Sowers L.C., Loeb L.A. Reverse chemical mutagenesis: identification of the mutagenic lesions resulting from reactive oxygen species-mediated damage to DNA. Proc. Natl. Acad. Sci. U.S.A. 91:1994;6609-6613.
95. Grosovsky A.J., DeBoer J.G., de Jong P.J., Drobetsky E.A., Glickman B.W. Base substitutions, frameshifts and small deletions constitute ionizing radiation-induced point mutations in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 85:1988;185-188.
96. Tindall K.R., Stein J., Hutchinson F. Changes in DNA base sequence induced by gamma-ray mutagenesis of lambda phage and prophage. Genetics. 118:1988;551-560.
97. Morningstar M.L., Kreutzer D.A., Essigmann J.M. Synthesis of oligonucleotides containing two putatively mutagenic DNA lesions: 5-hydroxy-2′-deoxyuridine and 5-hydroxy-2′deoxycytidine. Chem. Res. Toxicol. 10:1997;1345-1350.
98. Kreutzer D.A., Essigmann J.M. Oxidized deaminated cytosines are a source of C → T transitions in vivo. Proc. Natl. Acad. Sci. U.S.A. 95:1998;3578-3582.
99. McBride T.J., Schneider J.E., Floyd R.A., Loeb L.A. Mutations induced by methylene blue plus light in single-stranded M13mp2. Proc. Natl. Acad. Sci. U.S.A. 89:1992;6866-6870.
100. Wood M.L., Dizdaroglu M., Gajewski E., Essigmann J.M. Mechanistic studies of ionizing radiation and oxidative mutagenesis: genetic effects of a single 8-hydroxyguanine (7-hydro-8-oxoguanine) residue inserted at a unique site in a viral genome. Biochemistry. 29:1990;7024-7032.
101. Shibutani S., Takeshita M., Grollman A.O. Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxo-dG. Nature. 349:1991;431-434.
102. Cheng K.C., Cahill D.S., Kasai H., Nishimura S., Loeb L.A. 8-hydroxyguanine, an abundant form of oxidative DNA damage, causes G → T and A → C substitutions. J. Biol. Chem. 267:1992;166-172.
103. Reid T.M., Loeb L.A. Tandem double CC → TT mutations are produced by reactive oxygen species. Proc. Natl. Acad. Sci. U.S.A. 90:1993;3904-3947.
104. Newcomb T.G., Allen K.J., Tkeshelashvili L., Loeb L.A. Detection of tandem CC → TT mutations induced by oxygen radicals using mutation-specific PCR. Mutat. Res. 427:1999;21-30.
105. Kunkel T.A. DNA replication fidelity. J. Biol. Chem. 267:1992;18251-18254.
106. Feig D.I., Loeb L.A. Oxygen radical induced mutagenesis is DNA polymerase specific. J. Mol. Biol. 235:1994;33-41.
107. Jackson A.L., Chen R., Loeb L.A. Induction of microsatellite instability by oxidative DNA damage. Proc. Natl. Acad. Sci. U.S.A. 95:1998;12468-12473.
108. Jackson A.L., Loeb L.A. Microsatellite instability induced by hydrogen peroxide in Escherichia coli. Mutat. Res. 447:2000;187-198.
109. Rabinovitch P.S., Dziadon S., Brentnall T.A., Emond M.J., Crispin D.A., Haggitt R.C., Bronner M.P. Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis (in process citation). Cancer Res. 59:1999;5148-5153.
110. Ames B.N., Shigenaga M.K., Hagen T.M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. U.S.A. 90:1993;7915-7922.
111. Baik S.C., Youn H.S., Chung M.H., Lee W.K., Cho M.J., Ko G.H., Park C.K., Kasai H., Rhee K.H. Increased oxidative DNA damage in Helicobacter pylori-infected human gastric mucosa. Cancer Res. 56:1996;1279-1282.
112. R. Farinati, R. Cardin, G. Della Libera, et al., Lipid peroxidation and anti-oxidant defence in human gastric mucosa: effect of Helicobacter pylori, Eur. J. Gastroenterol. Hepatol. 5 (Suppl. 2) (1993) S9-S11.
113. R. Farinati, G. Della Libera, R. Cardin, et al., Gastric antioxidant, nitrites, and mucosal lipoperoxidation in chronic gastritis and Helicobacter pylori infection, J. Clin. Gastroenterol. 22 (1996) 275-281.
114. Farinati F., Cardin R., Degan P., Rugge M., Di Mario F., Bonvicini P., Naccarato R. Oxidative DNA damage accumulation in gastric carcinogenesis. Gut. 42:1998;31-356.
115. Weitzman S.A., Gordon L.I. Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis. Blood. 76:1990;655-663.
116. T.A. Brentnall, R.C. Haggitt, R.P.S., M.B. Kimmey, M.P. Bronner, D.S. Levine, K.V. Kowdley, A.C. Stevens, D.A. Crispin, M. Emond, C.E. Rubin, Risk and natural history ofcolonic neoplastic progression of patients with primary scleroxing cholangitis and ulcerative colitis, Gastroenterology 110 (1996) 331-338.
117. Brentnall T.A., Crispin D.A., Bronner M.P., Cherian S.P., Hueffed M., Rabinovitch P.S., Rubin C.E., Haggitt R.C., Boland C.R. Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res. 56:1996;1237-1240.
118. Willenbucher R.F., Aust D.E., Chang C.G., Zelman S.J., Ferrell L.D., Moore D.H., Waldman F.M. Genomic Instability is an early event during the progression pathway of ulcerative colitis-related neoplasia. Am. J. Pathol. 154:1999;1825-1830.
119. Brentnall T.A., Chen R., Lee J.G., Kimmey M.B., Bronner M.P., Haggitt R.C., Kowdley K.V., Hecker L.M., Byrd D.R. Microsatellite instability and K-ras mutations associated with pancreatic adenocarcinoma and pancreatitis. Cancer Res. 55:1995;4264-4267.
120. Ross R.K., Yuan J.-M., Yu M.C., Wogan G.N., Qian G.-S., Tu J.-T., Groopman J.D., Gao Y.-T., Henderson B.E. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet. 339:1992;943-946.
121. Blumberg B.S., Larouze B., London W.T., Werner B., Hesser J.E., Millman I., Saimot G., Payet M. The relation of infection with the Hepatitis B agent to primary hepatic carcinoma. Am. J. Pathol. 81:1975;669.
122. Hagen T.M., Huang S., Curnutte J., Fowler P., Martinez V., Wehr C.M., Ames B.N., Chisari F.V. Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma. Proc. Natl. Acad. Sci. U.S.A. 91:1994;12808-12812.
123. Kizaki M., Sakashita A., Karmakar A., Lin C.W., Koeffler H.P. Regulation of manganese superoxide dismutase and other anitoxidant genes in normal and leukemic hematopoietic cells and ther relationship to cytotoxicity by tumor necrosis factor. Blood. 82:1993;1142-1150.
124. Desmet W.J., Gerber M., Hoofnagle J.H., Manns M., Scheuer P.J. Classification of chronic hepatits: diagnosis, grading, and staging. Hepatology. 19:1994;1518-1520.
125. De Maria N., Colantoni A., Faguioli S., Liu G.-J., Rogers B.K., Farinati F., Van Thiel D.H., Floyd R.A. Association between reactive oxygen species and disease activity in chronic Hepatitis C. Free Rad. Biol. Med. 21:1996;291-295.
126. Farinati F., Cardin R., De Maria N., Libera G.D., Marafin C., Lecis E., Burra P., Floreani A., Cecchetto A., Naccarato R. Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J. Hepatol. 22:1995;449-456.
127. Shimoda R., Nagashima M., Sakamoto M., Yamaguchi N., Hirohashi S., Yokota J., Kasai H. Increased formation of oxidative DNA damage, 8-hydroxyguanosine, in human livers with chronic hepatitis. Cancer Res. 54:1994;3171-3172.
128. Factor V.M., Laskowska D., Jensen M.R., Woitach J.T., Popescu N.C., Thorgiersson S.S. Vitamin E reduces chromosomal damage and inhibits hepatic tumor formation in a transgenic mouse model. Proc. Natl. Acad. Sci. U.S.A. 97:2000;2196-2201.